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Despite frequent blood transfusions combined with
chelation therapy lead to an improved rate of survival,
endocrine disorders related to secondary hemosiderosis
such as short stature, delayed puberty and hypogonad-
ism are major problems in adolescent children with
thalassemia major. The aim of this study was to know
the description of height, growth velocity, bone age,
hemoglobin pretranfusion level and serum ferritin in
thalassemic patients.
The retrospective study of children hospitalized in
Pediatrics ward Sanglah Hospital Denpasar from
December 2010-February 2011.
Fifteen subjects were diagnosed as thalassemia major,
aged between 1.91 years - 13.5 years; 7 boys and 8 girls.
Two children aged less than 3 years and 7 children had
entered puberty. All patients had to undergo iron chela-
tion therapy deferioksamin with inadequate quality. Short
stature was found in 4 children (26%), all with growth
velocity of <5 cm/year. Clinically 1 person categorized as
delayed puberty. Mean hemoglobin pretranfusion levels
can be maintained &#8805; 8 mg/dl (10), the remainder
(5) has an average hemoglobin below 8 mg/dl. Four chil-
dren with serum ferritin over 3000 ng/ml, all with short
stature. In the radiological evaluation (bone age) 5 children
have delayed bone age.
Our study suggests that thalassemic patients, short
stature is found in 26% cases and all of them have entered
the age of puberty. All patients with short stature has
serum ferritin levels >3000 ng/ml.
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